Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunotherapy with levamisole: early decrease of cAMP levels in lymphocytes from treated cancer patients.

U H Lewinski, G M Mavligit, W J Thompson

|October 1, 1979

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Same author

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.

Cancer immunology, immunotherapy : CII·2001

Same author

Cationic lipid-mediated gene transfer: current concepts.

Current opinion in molecular therapeutics·2001

Same author

Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Same author

Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.

Anti-cancer drugs·2001

Same author

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.

Cancer chemotherapy and pharmacology·2001

Levamisole treatment in cancer patients significantly decreased lymphocyte cyclic adenosine monophosphate (cAMP) levels. Cyclic guanosine monophosphate (cGMP) levels remained unchanged, suggesting potential immune modulation pathways requiring further investigation.

Area of Science:

Immunology
Pharmacology
Oncology

Background:

Cancer patients often exhibit altered immune function.
Cyclic nucleotides like cAMP and cGMP play crucial roles in cellular signaling and immune responses.
Understanding drug effects on immune cell biochemistry is vital for cancer therapy.

Purpose of the Study:

To investigate the impact of Levamisole on lymphocyte cyclic nucleotide levels in cancer patients.
To determine if Levamisole alters endogenous cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in lymphocytes.

Main Methods:

A study involving 12 cancer patients receiving Levamisole (100 mg/m2 for two days) and 9 control patients.
Measurement of endogenous cAMP and cGMP in lymphocytes before, 24, and 48 hours after the first Levamisole dose.

Related Experiment Videos

Main Results:

A statistically significant decrease in lymphocyte cAMP levels was observed post-Levamisole administration.
No significant changes were detected in lymphocyte cGMP levels following Levamisole treatment.

Conclusions:

Levamisole administration leads to a significant reduction in lymphocyte cAMP in cancer patients.
The observed biochemical changes in cyclic nucleotides warrant further research into their correlation with cellular immune function modulation.